XENON PHARMACEUTICALS INC. (XENE)

SEC filing

XENON PHARMACEUTICALS INC.

XENE · CIK 1582313

4 · Aug 31, 2026 · Chief Medical Officer KENNEY CHRISTOPHER JOHN sold 7,068 Common Shares at $60.25/unit ($425.8K)

Chief Medical Officer KENNEY CHRISTOPHER JOHN sold 7,068 Common Shares at $60.25/unit ($425.8K)

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).